HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ragıp Ertaş Selected Research

Urticaria (Hives)

1/2023In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity.
1/2021Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
2/2016Adverse Reaction to Omalizumab in Patients with Chronic Urticaria: Flare Up or Ineffectiveness?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ragıp Ertaş Research Topics

Disease

5Chronic Urticaria
01/2023 - 02/2016
3Urticaria (Hives)
01/2023 - 02/2016
2Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 01/2019
1Familial dermographism
01/2023
1COVID-19
01/2021
1Rheumatoid Arthritis
09/2020
1Eczema
01/2019
1Eosinophilia
01/2019
1Dermatitis
01/2019
1Hypersensitivity (Allergy)
01/2019
1Ichthyosis (Xeroderma)
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Rosacea (Acne Rosacea)
01/2019
1Perioral Dermatitis
01/2019
1Netherton Syndrome
01/2019
1Anaphylaxis (Anaphylactic Shock)
02/2016
1Angioedema
02/2016

Drug/Important Bio-Agent (IBA)

4Omalizumab (Xolair)FDA Link
01/2021 - 02/2016
3Histamine Antagonists (Antihistamines)IBA
01/2023 - 02/2016
1COVID-19 VaccinesIBA
01/2023
1CarbohydratesIBA
01/2023
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
01/2021
1tofacitinibIBA
09/2020
1Immunoglobulin E (IgE)IBA
01/2019
1Immunologic Factors (Immunomodulators)IBA
01/2019
1AcaricidesIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2019
1AcitretinFDA Link
01/2019
1Monoclonal AntibodiesIBA
02/2016

Therapy/Procedure

4Therapeutics
02/2022 - 02/2016